C17H18FN3O3

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 9 USDMF, 6 CEP/COS, 8 JDMF, 3 EU WC, 5 KDMF, 4 NDC API, 26 Listed Suppliers

DEVELOPMENTS

80 Drugs in Development

80 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

702 FDF Dossiers, 61 FDA Orange Book, 360 Europe, 3 Canada, 20 Australia, 88 South Africa, 170 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML), SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 5 SPI Pharma, 10 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 7 Kirsch Pharma, 2 Cerata Pharmaceuticals LLP, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 BioSpectra, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 1 Gloria Interchem, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 1 JJ Chemicals, 22 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 39 Disintegrants & Superdisintegrants, 35 Granulation, 35 Thickeners and Stabilizers, 33 Solubilizers, 33 Direct Compression, 29 Parenteral, 28 Controlled & Modified Release, 23 Topical, 20 Lubricants & Glidants, 19 Film Formers & Plasticizers, 16 Taste Masking, 15 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 10 Emulsifying Agents, 8 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

64 News #PharmaBuzz

64 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 185 Regulatory FDF Prices, 2 Annual Reports

MARKET PLACE

74 APIs, 38 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 19 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

Xls

Filters

C17H18FN3O3

Filters

FILTER :

filter Company Reset all filters

1 All

01 1JJ Chemicals

filter Capability Reset all filters

filter Country Reset all filters

01

JJ Chemicals

DI CALCIUM PHOSPHATE

RDD

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Pharmaceutical Excipients offered by JJ Chemicals? Find C17H18FN3O3 to address your drug delivery challenges on PharmaCompass.

C17H18FN3O3

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers

9 USDMF

6 CEP/COS

8 JDMF

3 EU WC

5 KDMF

4 NDC API

26 Listed Suppliers

DEVELOPMENTS

80 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

702 FDF Dossiers

61 FDA Orange Book

360 Europe

3 Canada

20 Australia

88 South Africa

170 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML)

SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Rochem International Inc

5 SPI Pharma

10 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

2 Pfanstiehl

7 Kirsch Pharma

2 Cerata Pharmaceuticals LLP

2 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

12 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

35 BASF

1 BioSpectra

1 Clariant

11 Corel Pharma Chem

6 DFE Pharma

2 Esteem Industries

2 Finar

14 Gangwal Chemicals

1 Gloria Interchem

5 Ideal Cures

4 Ingredion Pharma Solutions

1 JJ Chemicals

22 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

2 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Pharmachem

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

30 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

11 Sigachi Industries

INJECTABLE;INJECTION - 200MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 400MG/200ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons